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Abstract 
The purpose of this study was to determine whether cognitive distortions, social support, 
and/or levels of coping skills predict quality of life (QOL) for women with SLE.  The 
total sample consisted of 62 women ranging in age from 18 to 55 years.  This study was 
conducted online via SurveyMonkey in an effort to reach the specialized SLE female 
population and recruit individuals who otherwise may not have been able to participate 
due to limitations in mobility and/or lack of transportation.  The measures consisted of 
the Inventory of Cognitive Distortions (ICD), the WHOQOL-BREF (WHOQOL), the 
Multidimensional Scale of Perceived Social Support (MSPSS), and the Brief COPE.  
Results revealed that 49.5% of the variability in scores on WHOQOL-BREF were 
attributable to differences in scores on the ICD.  A test of the individual predictors 
revealed that only social support and coping made significant contributions to the 
prediction of the QOL.  In other words, the linear combination of social support and 
coping is useful in predicting QOL.  Additionally, findings demonstrated that high levels 
of distorted thinking were highly correlated with lower QOL.   
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 Chapter 1: Introduction 
Statement of the Problem 
Approximately 5 million people throughout the United States have a form of 
systemic lupus erythematosus (SLE; D’Cruz, Khamashta, & Hughes, 2007).  SLE is a 
relapsing-remitting condition in which periods of mild disease activity alternate with 
flares of increased disease activity.  SLE is mainly manifested in women, but also found 
in children and men, with clinical and pathologic manifestations involving almost all 
bodily organs (Lau & Mak, 2009).  Symptoms can include fatigue, joint pain and 
sensitivity, malar rash on the face, and skin photosensitivity (D’Cruz et al., 2007).  
Complications can include kidney damage including kidney failure, cognitive and 
memory impairment, neuropsychiatric symptoms, blood disorders, and cardiovascular 
disease (Seshan & Jennette, 2009). 
 Chronic diseases such as SLE are the leading causes of suffering, disability, and 
death in the United States (Hanly et al., 2007).  Specifically, SLE affects not only 
patients’ physical health, but also their social, emotional, mental, and financial well-
being.  More than 16,000 new cases of lupus are reported annually across the country; 
however, that number may be higher due to the lack large-scale studies regarding this 
pervasive disease.  Additionally, the reported prevalence of SLE in the population is 20 to 
150 cases per 100,000 (D’Cruz et al., 2007).  Although anyone can acquire SLE, about 9 
out of 10 adults with lupus are women ages 15 to 45.  African American women are three 
times more likely to get lupus than Caucasian women.  SLE is also common in Latina, 
Asian, and Native American women (Skamra & Ramsey-Goldman, 2010).  Further, men 
are at a higher risk before puberty and after age 50.  Despite an increase in lupus in men 
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in these age groups, two thirds of the people who have lupus before puberty and after age 
50 are women (Pons-Estel, Alarcon, Scofield, Reinlib, & Cooper, 2010).  African 
American Latins tend to get SLE at a younger age and have more severe symptoms, 
including kidney problems, seizures, strokes, and dangerous swelling of the heart muscle 
(Uramoto et al., 1999). 
Persons with SLE may experience a wide range of psychological and social 
problems that are not always fully captured by descriptions of the disease’s physiological 
consequences alone (Strand et al., 2003).  Symptoms may include difficulty 
concentrating, sleeping, prolonged grief, excessive fear, anxiety, and depression (Strand 
et al., 2003).  Many individuals with SLE also struggle with learning how to accept 
having the illness (Waterloo, Omdal, Husby, & Mellgren, 1998).  Low self-esteem and 
feelings of guilt are common among individuals with SLE (Waterloo et al.,1998), leading 
to depression in 30% to 40% of patients (Karlson et al., 2004). 
It is not surprising, then, that perceived quality of life (QOL) also suffers.  Factors 
contributing to low perceived QOL include both physical and psychological difficulties.  
Physically, one must adapt to life with new limitations in energy level and joint pain. 
Additionally, potential medical complications commonly require tetracycline antibiotics, 
which can impact an individual’s sensitivity to sunlight may also occasionally cause 
“phototoxic” reactions.  These will lead to easy sun burning that will require extra 
protection against sunlight (Kim & Chong, 2013).  Psychologically, the person may 
grieve the loss of his or her personal identity and cherished goals, which heightens 
vulnerability to depression, anxiety, substance abuse and suicidality (Kennedy, 2012).
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Economically, studies have shown that SLE is associated with substantial burden, 
in terms of health care resource utilization, as well as losses of productivity due to work 
capacity impairment (Carls et al., 2009).  Direct medical costs, indirect costs due to 
absenteeism, and indirect costs due to short-term disability in patients with SLE were 
estimated at $21,499, $3,824, and $2,474, respectively, compared with $8,008, $4,430, 
and $1,169, respectively, in persons without SLE (Zhu, Tam, V. W. Lee, K. K. Lee, & E. 
K. Li, 2009a).  Generally, costs for inpatient care represent the largest proportion of direct 
costs. 
SLE has an impact on a patient’s QOL and ability to work (Krishnan, 2006).  
Campbell, Cooper, and Gilkson (2008) analyzed the impact of SLE on employment, 
specifically work status and predictors of job loss, between 2007 and 2008.  A follow-up 
study found that 26% of patients with SLE who were working the year before the 
diagnosis or corresponding reference year had stopped working at follow-up (Campbell, 
Cooper, & Gilkson, 2009).  Ninety-two percent of patients had stopped working due to 
their health statuses. Furthermore, 28% of patients were unable to work for a period of 
two or more months (Campbell et al., 2009).  In sum, SLE impacts QOL in SLE patients 
and understanding what factors predict QOL is important in being able to better treat this 
population. 
Purpose of the Study 
The purpose of this study was to determine whether cognitive distortions, social 
support, and/or levels of coping skills predict QOL in women with SLE.  It was proposed 
that QOL would be predicted by a linear combination of distorted thinking, social 
support, and levels of coping.  Understanding this relationship may illustrate the need for 
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health care professionals in primary care offices, specialty clinics, and other settings to 
receive better training to implement specific therapeutic interventions to modify SEL-
related dysfunctional thinking and enhance support  in an effort to promote effective 
coping skills and improve the quality of life of those who SLE. 
Literature Review  
Systemic lupus erythematosus.  SLE is an autoimmune disease that causes a 
chronic inflammatory condition.  The inflammation triggered by SLE can affect many 
organs in the body, including the skin, joints, kidneys, lung, and nervous system.  SLE 
has a wide range of symptoms.  The most common symptoms are joint pain, skin rash, 
and fever.  Symptoms can develop slowly or appear suddenly.  Many patients with SLE 
have flares, in which symptoms suddenly worsen and then settle down for long periods 
(Somers, Thomas, Smeeth, Schoonen, & Hall, 2007). 
SLE is a chronic and relapsing inflammatory disease.  It is marked by periods of 
remission (no symptoms) that alternate with flares of active disease when symptoms 
suddenly worsen.  Flares tend to diminish after menopause (Fayyaz et al., 2015).  
Symptom-free periods can sometimes last for years, but the course of SLE is 
unpredictable and varies greatly from person to person.  Some patients have mild forms 
of lupus with occasional skin rashes, fever, fatigue, or joint and muscle aches. Sometimes 
lupus remains mild, but other times it may become more severe menopause (Fayyaz et 
al., 2015).  Severe lupus involves serious health complications and extensive internal 
organ damage, including damage to  the heart, lungs, kidneys, and brain. 
Prevalence.  Studies in the United States conducted between 1950 and 2012 
reported an increasing incidence of SLE.  Reported values for the incidence and 
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prevalence of SLE vary considerably worldwide.  In the United States, the prevalence of 
SLE ranges from 3.2 to 517.5 cases per 100,000 individuals, in contrast to prevalence in 
India being 3.2 per 100,000 and the prevalence among Afro-Caribbean people living in 
the United Kingdom being 517.5 per 100,000 (Somers et al., 2007). 
Two unique and particularly comprehensive strategies for case ascertainment in 
SLE are capture-recapture methods and the community-oriented program for control of 
rheumatic diseases (COPCORD) approach.  Capture-recapture methods evaluate the 
completeness of case ascertainment by estimating the number of cases that are missed 
when multiple data sources are used for data analysis.  Two U.S. studies using this 
methodology derived almost identical incidence and prevalence values: the Michigan 
Lupus Epidemiology and Surveillance Program reported an incidence of 5.5 per 100,000 
per year and a prevalence of 72.8 per 100,000 and the Georgia Lupus Registry reported 
an incidence of 5.6 per 100,000 per year and a prevalence of 74.4 per 100,000.  Other 
studies using these approaches provides incidence estimates of 1.0 per 100,000 per year 
in Denmark and prevalence estimates of 21.9 to 28.3 per 100,000 in Denmark and 25.4 
per 100,000 in Ireland (Alamanos et al., 2003). 
Trends and patterns.  Despite variations in the reported incidence and prevalence 
rates of SLE, apparent trends have emerged.  SLE typically presents between the ages of 
15 and 45 years, with a 9 to 1 ratio of female to male patients.  Ethnic disparities are also 
widely recognized, with non-White populations generally having higher incidence and 
prevalence of SLE compared to White populations.  For example, in the U.S., the 
incidence and prevalence of SLE in African Americans is approximately two to five times 
higher than in European Americans.  In the U.K., the prevalence of SLE is six to eight 
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times higher in individuals of African ancestry and in Indo-Asian people than in White 
populations.  The disease is also two to four times more common among Aboriginal 
individuals compared to non-Aboriginal individuals living in Australia, Canada, and the 
U.S.  The incidence and prevalence of SLE is also higher in other populations that 
include individuals of African, Asian, and Aboriginal ancestry (Alamanos et al., 2003). 
Diagnosis.  Because SLE can have a wide variety of symptoms and different 
combinations of organ involvement, no single test establishes its diagnosis.  To help 
doctors improve the accuracy of the diagnosing SLE, 11 criteria were established by the 
American Rheumatism Association (D’Cruz et al., 2007).  Some individuals suspected of 
having SLE may never develop enough criteria for a definite diagnosis.  Other people 
accumulate enough criteria only after months or years of observation.  For individuals 
who meet four or more of these criteria, the diagnosis of SLE is strongly suggested.  
Nevertheless, health care providers in some settings may diagnose of SLE in people with 
only a few of these classic criteria, and treatment may sometimes be instituted at this 
stage.  Among people meeting minimal criteria, some may later develop other symptoms, 
whereas others may not (Agmon-Levin, Mosca, Petri, & Shoenfeld, 2012).   
As stated, there are 11 criteria used for diagnosing SLE: (a) malar (over the 
cheeks of the face) or “butterfly” rash; (b) discoid skin rash (patchy redness with 
hyperpigmentation and hypopigmentation that can cause scarring); (c) photosensitivity 
(skin rash in reaction to sunlight [ultraviolet light] exposure); (d) mucous membrane 
ulcers (spontaneous sores or ulcers of the lining of the mouth, nose, or throat); I arthritis 
(two or more swollen, tender joints of the extremities); (f) pleuritis or pericarditis 
(inflammation of the lining tissue around the heart or lungs, usually associated with chest 
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pain upon breathing or changes of body position); (g) kidney abnormalities (abnormal 
amounts of urine protein or clumps of cellular elements called casts detectable with a 
standard urinalysis; (h) brain irritation (manifested by seizures [convulsions] and/or 
psychosis, referred to as “lupus cerebritis”); (i) blood abnormalities, including blood 
count abnormalities (low white blood count [WBC], red blood count [RBC], or platelet 
count on routine complete blood count testing), leukopenia, anemia, and 
thrombocytopenia, each of which are detectable with standard complete blood count 
testing (CBC); (j) immunologic disorder as indicated by abnormal immune tests 
(including anti-DNA or anti-Sm [Smith] antibodies, falsely positive blood test for 
syphilis, anticardiolipin antibodies, lupus anticoagulant, or positive LE prep test); and (k) 
antinuclear antibodies (positive ANA antibody testing indicating antinuclear antibodies in 
the blood; Agmon-Levin et al., 2012). 
Ultimately, in patients with kidney disease from SLE (lupus nephritis), a kidney 
biopsy may be necessary to both define the cause of the kidney disease as being lupus-
related as well as to determine the stage of the kidney disease in order to optimally guide 
treatments.  Kidney biopsies are often performed by fine-needle aspiration of the kidney 
under radiology guidance, but in certain circumstances, a kidney biopsy can be done 
during an open abdominal operation (Agmon-Levin et al., 2012).  
In addition to the 11 criteria, other tests can be helpful in evaluating people with 
SLE to determine the severity of organ involvement.  These include routine testing of the 
blood to detect inflammation (for example, the erythrocyte sedimentation rate [ESR] and 
the C-reactive protein [CRP]), blood-chemistry testing, direct analysis of internal body 
fluids, and tissue biopsies (D’Cruz et al., 2007).  Abnormalities in body fluids (joint or 
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cerebrospinal fluid) and tissue samples (kidney biopsy, skin biopsy, and nerve biopsy) 
can further support the diagnosis of SLE.  The appropriate testing procedures are selected 
for the patient individually by their doctors (Agmon-Levin et al., 2012). 
Prognosis.  The idea that lupus is generally a fatal disease is incorrect.  Medical 
science has not yet developed a method for curing lupus, and there are cases in which 
people have died from SLE complications; however, taking medication(s) as prescribed, 
knowing when to seek help for unexpected side effects of medications or new 
manifestations of lupus, and following the physicians’ instructions have improved the 
prognosis of individuals diagnosed with SLE (Abu-Shakra et al., 2005) 
Because of more effective and aggressive treatments, the prognosis for SLE has 
improved markedly over the past two decades.  Treatment early in the course of the 
illness that controls initial inflammation can help to improve long-term outlook.  Over 
95% of people with lupus survive at least 10 years (Shelman & Merrell, 2006). 
Physical impact of SLE.  Almost 85% of patients with SLE experience problems 
associated with abnormalities in the blood, and about half of patients with SLE are 
anemic.  Between 34% and 42% of patients with SLE have antiphospholipid syndrome 
(APS).  This is a disorder of blood coagulation related to the presence of autoantibodies 
called lupus anticoagulant and anticardiolipin.  APS can cause blood clots, which most 
often occur in the deep veins of the legs, a condition called deep vein thrombosis.  
Patients with SLE and other autoimmune disorders have a greater risk for developing 
lymph system cancers such as Hodgkin’s disease and non-Hodgkin’s lymphoma (Konya, 
Paz, & Tsokos, 2014). 
LUPUS, COGNITIVE DISTORTIONS, & COPING                         9 
 
The risk for cardiovascular disease, heart attack, and stroke is much higher than 
average in patients with SLE, and heart disease is a primary cause of death.  The chronic 
inflammation associated with SLE can cause plaque build-up in the heart’s arteries 
(atherosclerosis), which can lead to coronary heart disease and heart attack.  SLE also 
affects blood vessels and circulation.  In addition, SLE treatments (particularly 
corticosteroids) can affect cholesterol, weight, and other factors that harm the heart 
(Konya et al., 2014). 
Inflammation of the lung tissue is called lupus pneumonitis.  It can be caused by 
infections or by the SLE inflammatory process.  Symptoms are the same in both cases: 
fever, chest pain, labored breathing, and coughing.  Rarely, lupus pneumonitis becomes 
chronic and causes scarring in the lungs, which reduces their ability to deliver oxygen to 
the blood (Konya et al., 2014). 
Kidney complications, such as inflammation of the kidneys (lupus nephritis), are 
common in SLE.  About one third of patients have lupus nephritis at the time of diagnosis 
and more than half develop it within 10 years after lupus symptoms begin.  In its early 
stages, lupus nephritis can cause fluid build-up leading to swelling in the extremities 
(feet, legs, hands, arms) and overall weight gain (Konya et al., 2014).  If left untreated, 
lupus nephritis may progress to complete kidney failure (end-stage renal disease). 
Nearly all patients with SLE report some symptoms relating to problems that 
occur in the central nervous system (CNS), which includes the spinal cord and the brain. 
Symptoms vary widely and may overlap with psychiatric or neurologic disorders.  They 
may also be caused by of some of the medications used for treating SLE.  The most 
serious CNS disorder is inflammation of the blood vessels in the brain (CNS vasculitis), 
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which occurs in about 10% of patients with SLE.  Fever, seizures, psychosis, and even 
coma also can occur (Konya et al., 2014). 
Infections are a common complication and a major cause of death in all stages of 
SLE.  Patients are not only prone to ordinary bacterial and viral infections, but they are 
also susceptible to fungal and parasitic infections, which are common in people with 
weakened immune systems such as those with SLE.  They also face an increased risk for 
urinary tract, herpes, salmonella, and yeast infections.  Corticosteroid and 
immunosuppressant drug treatments used for SLE also increase the risk for infections 
(Konya et al., 2014). 
Many patients with SLE suffer gastrointestinal problems, including nausea, 
weight loss, mild abdominal pain, diarrhea, and gastroesophageal reflux disorder 
(heartburn).  SLE can also affect organs located in the gastrointestinal system, such as the 
liver, gallbladder, pancreas, and bile ducts (Konya et al., 2014). 
Patients with SLE often experience muscle aches and weakness.  SLE can also 
cause pain, stiffness, and swelling in the joints.  Notably, unlike in rheumatoid arthritis, 
the arthritis caused by SLE almost never leads to destruction or deformity of joints.  In 
addition, patients with SLE commonly experience reductions in bone mass density 
(osteoporosis) and have a higher risk for fractures, irrespective of taking corticosteroids 
(which can increase the risk for osteoporosis; Konya et al., 2014). 
 Neurocognitive impact of SLE.  Cognitive impairment (CI) in SLE is 
characterized by deficits in attention, learning and recall, verbal and nonverbal fluency, 
language, visuospatial skills, executive functions, and motor dexterity, and is probably 
due to damage of the fronto-subcortical circuits (Kozora, Thompson, West, & Kotzin, 
LUPUS, COGNITIVE DISTORTIONS, & COPING                         11 
 
1996).  CI in SLE patients has been found in between 3% and 80% of patients (Sanna et 
al. 2013). 
Economic impact of SLE.  Patients with severe presentations have been found to 
use more health care resources over a 2-year follow-up period, and medical imaging and 
biopsies were performed more frequently in patients with severe symptoms (95% versus 
77%; p = .002; Zhu, Tam, & E. K. Li, 2011).  Further, corticosteroids (96% versus 45%; 
p = .001), immunosuppressants, (93% versus 70%; p = .003), and antihypertensives (89% 
versus 45%; p = .001) were prescribed more frequently in patients with severe 
presentations of the disease (Zhu et al., 2011).  Overall, specialist visits occurred more 
frequently in patients with severe disease presentations, particularly to ophthalmologists 
(54% versus 17%; p = .001), cardiologists (32% versus 13%; p = .023), nephrologists 
(54% versus 13%; p = .001), psychiatrists (14% versus 0%; p = .006), and internists 
(32% versus 11%; p = .011).  Inpatient stays and ER visits also occurred more frequently 
in patients with severe presentations compared to patients with non-severe presentations 
(59% versus 19% and 48% versus 26%, respectively; Zhu et al., 2011). 
Results have shown that SLE is associated with substantial economic burden in 
terms of health care resources utilization, as well as losses of productivity due to work 
capacity impairment (Carls et al., 2009).  Direct medical costs, indirect costs due to 
absenteeism, and indirect costs due to short-term disability in patients with SLE were 
estimated at $21,499, $3,824, and $2,474, respectively, compared with $8,008, $4,430, 
and $1,169, respectively, in persons without SLE (Zhu, Tam, V. W. Lee, K. K. Lee, & E. 
K. Li, 2009b).  Generally, costs for inpatient care represented the largest proportion of 
direct costs, suggesting that at least 17% and up to 56% of annual direct costs were 
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incurred by less than 27% of the population (Panopalis et al., 2008).  Up to 56% of direct 
annual costs were incurred by less than 27% of the population (Panopalis et al., 2008).  
Furthermore, the estimates of indirect costs are most likely to be underrated because these 
studies rarely take into account the productivity losses incurred by unpaid caregivers 
(Fautrel & Guillemin, 2002).  Among cost predictors, poor physical or mental health, low 
social support, high education level, unemployment, and high disease activity were 
associated with high indirect costs (Pelletier, Ogale, Yu, Brunetta, & Garg, 2009).  In 
regard to the impact of lupus flare ups (exacerbations of the disease) on costs of SLE, 
patients with flares incur significantly higher direct and indirect costs compared with 
those without flares (Lacaille, Clarke, Bloch, Danoff, & Esdaile, 1994).  In addition, 
multi-organ flares or renal/neuropsychiatric flares have been found to be more costly than 
single-organ flares or other minor organ flares (Sutcliff, Clarke, Taylor, Frost, & 
Isenberg, 2000). 
Cognitive distortions and SLE.  The cognitive model posits that thinking 
patterns influence behavioral, emotional, and even physiological responses.  A. T. Beck et 
al. (1979) described depression as a thinking disorder characterized by specific 
systematic cognitive errors.  These systematic thinking errors are believed to result in 
erroneous thoughts, or cognitive distortions (A. T. Beck, 1967).  A. T. Beck originally 
identified six cognitive distortions: arbitrary inference, selective abstraction, 
overgeneralization, magnification and minimization, personalization, and absolutistic, 
dichotomous thinking.  Since the introduction of A. T. Beck’s six original cognitive 
distortions, much attention has been given to thinking patterns in clinical populations.  
Burns (1980, 1990) went on to add to and simplify A. T. Beck’s six original cognitive 
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distortions as well as to borrowing from Ellis (1962, 1976), ultimately identifying 10 
cognitive distortions.  Burns’s greatest contribution in this realm may have been 
presenting these concepts in a way that a typical patient could readily understand and 
relate.  These 10 distortions are all-or-nothing thinking, discounting the positives, 
emotional reasoning, jumping to conclusions, labeling, magnification, mental filter, 
overgeneralization, blaming and personalization, and should-statements (Burns, 1980, 
1990).  Others have identified even more thinking errors, such as comparison, 
externalization of self-worth, and perfectionism (Freeman & DeWolf, 1989; Freeman & 
Oster, 1999). 
Several instruments have been designed to clinically assess the construct of 
cognitive distortions.  These instruments include the Dysfunctional Attitude Scale (DAS; 
Weissman, 1979; Weissman & A. T. Beck, 1978), the Cognitive Bias Questionnaire 
(CBQ; Krantz & Hammen, 1979), the Automatic Thoughts Questionnaire (ATQ; Hollon 
& Kendall, 1980), the Cognitive Error Questionnaire (CEQ; Lefebvre, 1981), the 
Cognitive Distortion Scale (CDS; Briere, 2000), and the Inventory of Cognitive 
Distortions (ICD; Yurica & DiTomasso, 2001).  These instruments vary in both clinical 
usage and distortions assessed, with the ATQ, DAS, and CEQ designed specifically for 
use with individuals diagnosed with depression.  Inconsistencies in regard to the type and 
number of distortions assessed impacts clinical utility, as the DAS, CBQ, ATQ, CEQ, and 
CDS do not measure all distortions found in the literature. 
Major depression is one of the most frequent psychiatric disorders observed in 
patients with SLE, with point prevalence rates between 10.8% and 39.6% (Shapiro, 
2007).  This is much higher than in the general population.  Researchers sought to 
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determine the prevalence of moderate or severe depressive symptoms and to determine 
factors associated with these depressive symptoms in a large cohort of patients with SLE 
(Bachen, Chesney, & Criswell, 2009).  Researchers found that 41.7% of patients reported 
moderate to severe depressive symptoms, consistent with previous reports highlighting 
the significance of depression in this population (Stojanovich, Zandman-Goddard, 
Pavlovich, & Sikanich, 2007; L. Zhang, Fu, Yin, Q. Zhang, & Shen, 2017). 
Coping skills and SLE.  In the field of health psychology, there are two major 
types of coping strategies: problem-focused (aimed at doing something active to modify a 
stressful situation, namely directed at reducing the threats and losses due to the illness) 
and emotion-focused (aimed at thinking or feeling in a different way about a stressful 
situation, namely directed at reducing the negative emotional consequences; Lazarus, 
1993).  Another distinction present in the literature is between active coping (behavioral 
or psychological efforts to change the stressful situation or the way one thinks or feels 
about a stressful situation) and avoidant coping (behaviors, such as drug use, or mental 
conditions, such as daydreaming about things other than the stressful event, that move 
away from the stressful event; Holahan & Moos, 2007). 
Appraisal of stress has been related to flares in SLE (Birmingham et al., 2006).  
Recommendations for lupus patients to reduce perceived stress are based on numerous 
studies establishing the association between daily stress and disease exacerbation.  For 
example, Peralta-Ramírez et al. (2004) evaluated 58 patients with lupus (46 with SLE and 
12 with CCL) for 6 months and found that chronic stress worsened the symptoms of the 
disease to the greatest degree, and this was observed in up to 74% of patients.  They also 
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found that 21% of patients with higher levels of the disease experienced deterioration 1 
day after stress was increased.   
Once an event has occurred and been appraised as a stressor, the second process 
relates to how the individual self-regulates and reduces stress, referred to as ‘‘coping’’ 
(Birmingham et al., 2006).  Some of these coping strategies may prove beneficial, 
whereas others may instead prove to be ‘‘maladaptive’’ or less effective (Lazarus, 2000). 
A meta-analysis showed emotion-focused strategies to be less effective and to be 
related to poor mental health in comparison to problem-focused coping (Penley, Tomaka, 
& Wiebe, 2002).  In addition, disengagement coping is considered a psychological risk 
factor or a nonadaptive response to stressful events (Bricou et al., 2006).  The course of 
the disease and the mental well-being of SLE patients have been shown to be influenced 
by coping strategies applied; disengaging and emotional coping styles have been 
described to interfere with the course of the disease, including patients’ mental well-being 
and the QOL (Bricou et al 2006). 
Anxiety and depression, which are frequently caused by daily stress, are the most 
prevalent psychological disorders experienced by lupus patients, affecting up to 40% of 
patients (Fonseca, Bernardes, Terroso, de Sousa, & Figueiredo-Braga, 2014).  
Furthermore, it is evident that lupus patients are dissatisfied with the treatment of both 
these disorders, indicating that lupus is currently being mismanaged and that patients’ 
concerns are not being dealt with adequately (Figueiredo-Braga et al., 2018).  These 
disorders, together with the chronic nature of the disease and its implications, not only 
affect the patient’s physical and psychological well-being, but they also seriously limit 
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his or her QOL.  It is widely accepted that adequate coping strategies can improve the 
QOL of patients with lupus (Figueiredo-Braga et al., 2018). 
CBT and SLE.  Researchers conducted studies regarding the effectiveness of 
cognitive-behavioral interventions in improving psychosocial stress and enhancing the 
well-being of individuals with SLE (Greco, Rudy, & Manzi, 2004).  The results suggested 
that such interventions significantly reduced stress, anxiety, and depression, considerably 
improved QOL, and reduced some somatic symptoms (Greco et al., 2004).  With regard 
to the emotional variables, it should be highlighted that, in addition to initially high levels 
of chronic stress, SLE patients have shown levels of anxiety and moderate levels of 
depression that were higher than average in the general population (Segui et al., 2000).  
After therapy, levels of anxiety and depression among patients treated with CBT were 
considerably lower and even fell below the population average (A. T. Beck, Steer, & 
Garbin, 1988). 
Social support and SLE.  Individuals with SLE can feel alone and isolated, and 
negative responses to their diagnosis such as disbelief or minimizing the problem might 
deter them from disclosing or seeking support from others in their social networks 
(Coursaris & Lin, 2009).  Improving awareness of SLE in the general population and also 
for general practitioners or non-specialist treatment providers might have benefits for 
SLE patients (Revenson, 1993).  In particular, increasing awareness of the subjective 
symptoms of lupus could help patients feel that their illness is understood by those 
involved in SLE treatment.  In general, the findings suggest that lupus support groups are 
a potentially valuable source of informational and emotional support (Somers et al., 
2014).  Support groups have been shown to help buffer the feelings of isolation brought 
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on by a lack of understanding from patients’ other social connections and, thus, may 
especially aid emotion-focused coping (Corcoran & Wall, 2000). 
For many reasons, Internet-mediated communication has become popular for 
patients suffering of various health conditions, mainly due to the increasing ease of its 
use and accompanied by reduced costs (Mazzoni & Cicognani, 2011).  Internet forums 
currently represent an opportunity for sharing experiences and social support among 
patients with chronic conditions, including SLE (Mendelson, 2003).  A study was 
conducted to describe the demand and supply of social support through the Internet in 
relation to the description of personal illness experiences.  All the posts (118) from an 
Italian forum for SLE patients were collected and analyzed, combining qualitative 
content analysis with statistical textual analysis.  The results showed different purposes 
for posts: starting new relationships, seeking information, receiving emotional support, 
and giving contributions (Mazzoni & Cicognani, 2014). 
Quality of life following diagnosis.  QOL among SLE patients is an area of great 
interest to patients, family members, researchers, and health professionals in specialty 
and primary care settings.  Although SLE can cause major organ damage, there are also 
many symptoms that, although they do not lead directly to major morbidity, can have a 
significant impact on a patient’s life, including fatigue, chronic pain, sleep disturbances, 
headaches, and hair loss (Gallop et al., 2012).  In part as a result of this, health-related 
quality of life (HRQOL) is generally poorer in patients with SLE than in the general 
population, and the reductions are similar to, or even exceed, those for other chronic 
diseases (McElhone, Abbott, & Teh, 2006). 
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Patients with SLE report reductions in all aspects of HRQOL, including physical 
and mental health, vitality, pain, and social and emotional functioning.  HRQOL is 
influenced by a complicated interplay between disease and environmental factors, and 
determinants include disease manifestations, particularly fatigue, disease activity, and 
damage accrual, as well as the patient’s level of helplessness and ability to cope with the 
disease.  Multiple other symptoms have been associated with poor HRQOL, including 
depression, anxiety, and neuropsychiatric and cutaneous manifestations. 
Over the last decade, survival of patients with SLE has significantly improved 
(Trager & Ward, 2001).  Moreover, many studies demonstrated that patients’ HRQOL 
depends on treatments’ efficacy, such as the efficacy of corticosteroids and 
hydroxychloroquine on psychosocial factors such as quality of social relationships and 
perceived self-efficacy in the management of the disease (Sutanto et al., 2013).  A recent 
literature review showed that social relationships have an impact on physical and 
psychological components of SLE patients’ HRQOL.  Most of the literature on social 
support and self-efficacy as predictors of patients’ HRQOL is based on cross-sectional 
studies, which limits attempts to determine cause and effect relationships.  Unlike cross-
sectional studies, this longitudinal, prospective study aimed to evaluate the independent 
contribution of social support and self-efficacy to patients’ subsequent HRQOL after 
controlling for patients’ prior HRQOL. 
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Chapter 2: Hypotheses 
This study tested four hypotheses. Based on the existing literature, the following 
hypotheses were developed: 
Hypothesis 1 
It was hypothesized that there would be a negative linear correlation between 
frequency of distorted thinking and QOL.  
Hypotheses 2 
It was hypothesized that there would be a positive significant correlation between 
social support and QOL.  
Hypotheses 3 
It was hypothesized that levels of coping would be positively correlated with 
QOL.  
Hypotheses 4 
It was hypothesized that the linear combination of cognitive distortions, social 
support, and levels of coping would significantly predict level of QOL. 
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Chapter 3: Method 
Design 
A cross-sectional correlational/regression design was employed (a) to assess the 
psychometric properties of the ICD by comparing total scores on this instrument with 
total scores on the World Health Organization Quality of Life-BREF instrument 
(WHOQOL-BREF), (b) to investigate the relationship between QOL as measured by the 
WHOQOL-BREF and level of coping skills as measured by the Brief COPE, (c) to 
investigate the relationship between QOL as measured by the WHOQOL-BREF and 
levels of  social support as measured by the  by the Social Support Behavior Scale (SSB), 
and (d) to test the predictive capacity of three predictors on QOL. 
Participants 
The total sample consisted of 62 women ranging in age from 18 to 55 years.  The 
sample size is based on Tabachnick and Fidell’s recommendation for a medium effect 
size, at the .05 level of significance with 80% power.  
Inclusion criteria.  Participants were required to meet predetermined conditions 
in order to be included in this study.  First, participants had to be diagnosed with SLE for 
at least one calendar year prior to the commencement of the study.  Second, participants 
were required to be between the ages of 18 and 55.  Third, participants must have had at 
least a self-reported eighth-grade education and be fluent in written and spoken English 
to ensure they would be able to read and understand the measures. 
Exclusion criteria.  Participants were excluded from the study if they reported 
that they did not have SLE diagnoses, were below 18 years of age or older than 55, were 
unable to speak and read English fluently, or had less than an eighth-grade education.  
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Participants were also excluded if they did not fill out the questionnaires in their entirety.  
Prior to completing the surveys, each participant completed five eligibility questions.  If 
they answered “No” to any of the preliminary questions, they were not eligible to 
complete the surveys and the survey was discontinued immediately. 
Measures 
Study materials included a cover letter and four self-report questionnaires.  The 
cover letter informed the potential participants about the general purpose of the study, 
potential risks of participation, and the right to withdraw from the study at any time.  The 
questionnaires consisted of the ICD (Yurica & DiTomasso, 2001), the WHOQOL-BREF 
(WHOQOL group, 2004), the MSPSS (Zimet, Dahem, Zimet, & Farley, 1988) and the 
Brief COPE (Carver, 1997).  The total administration time for the survey packet was 
approximately 20 to 30 minutes. 
Inventory of Cognitive Distortions.  The ICD is a 69-item self-report survey 
designed to measure the frequency of 11 factor-analyzed cognitive distortions (Yurica & 
DiTomasso, 2001).  Items are scored on a 5-point Likert scale, ranging from 1 (never) to 
5 (always).  Total possible scores range from 69 to 345.  Lower scores reflect lower 
frequencies of cognitive distortions, whereas higher scores reflect more frequent 
distortions.  The score is obtained through addition of the numerical ratings.  
The ICD has excellent internal consistency and test-retest validity.  The ICD was 
originally designed for and validated with an adult clinical population exhibiting 
symptoms of depression and anxiety.  One study examining the frequency of cognitive 
distortions in medical patients found high internal consistency (α = .97; Uhl, 2007). 
Yurica (2002) reported a test-retest reliability of .998 in a sample of 28 adults.  Content 
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validity was established for the ICD during the construction of the instrument.  A panel of 
three cognitive therapy experts reviewed and agreed unanimously on each of the 69 items 
(Yurica, 2002).  In addition, convergent validity has been demonstrated, with the ICD 
correlating with measures of psychopathology and pervasive negative attitudes toward 
the self, world, and future.  Yurica found that the ICD correlates with the Beck 
Depression Inventory (BDI-II; r = .70; A. T. Beck, Steer, & Brown, 1996), the Beck 
Anxiety Inventory (BAI; r = .59; A. T. Beck & Steer, 1990), and Weisman and Beck’s 
Dysfunctional Attitude Scale (DAS; r = .70; Weissman & A. T. Beck, 1978).  
The ICD has been identified as a useful tool for measuring cognitive distortions 
and patterns of dysfunctional thinking.  It can be used for a variety of reasons in CBT 
settings, including intake assessment and as a marker for treatment progress gleaned 
through baseline and outcome assessment.  It has also been used for research in 
establishing relationships between cognitive distortions and psychological diagnoses for 
both clinical syndromes and personality disorders (Rosenfield, 2004), anxiety and 
depression in adults diagnosed with ADHD (Strohmeier, 2013), parental stress and child 
psychopathology (Kennedy, 2012), and psychological and behavioral outcome factors in 
medical patients (Uhl, 2007), family medicine outpatients (Goins, 2008), and overweight 
and obese individuals (Shook, 2010), among others.  
WHOQOL-BREF.  The WHOQOL-BREF is a 26-item self-report survey 
designed to measure QOL (WHOQOL Group, 1998).  The 26 items are divided into two 
global QOL item categories and 24 specific QOL item categories.  The scale consists of 
four domains: physical health, psychological health, social relationships, and 
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environment.  Items are scored on a 5-point Likert scale, ranging from 1 (not at all) to 5 
(extremely). 
Respondents are asked to answer how much each item pertains to them over the 
past 2-week period.  The score is obtained by calculating the mean score for each domain, 
then multiplying the mean score by 4.  Scores for each domain range from 4 to 20, which 
is comparable to the WHOQOL-100.  Each domain score can be transformed to a scale 
ranging from 0 to 100, if desired.  A low score reflects a low QOL and a high score 
reflects a high QOL.  The first two items are examined separately, as these items assess 
the person’s overall perception of QOL and health.  
The WHOQOL-BREF demonstrates satisfactory internal consistency and 
discriminant validity among spinal cord injury (SCI) survivors (Jang, Hsieh, Wang, & 
Wu, 2004), as well as item-domain validity (r = 0.41 to 0.77), and moderate to high 
reliability (α = 0.74 to 0.87; Hill, Noonan, Sakakibara, Miller, & SCIRE Research Team, 
2010).  Test developers reported the Cronbach’s α coefficients as follows: .80 for 
physical, .76 for psychological, .66 for social, and .80 for environment (WHOQOL 
Group, 1998).  When tested for use with medical patients, the WHOQOL-BREF 
demonstrated internal consistency in three of four domains (Jang et al., 2004).  The social 
relationships domain did not demonstrate high internal consistency (α = .55), likely due 
to the small number of items within this domain (3 items).  Subscale correlations confirm 
construct validity among the physical health (0.55 to 0.73), psychological health (0.59 to 
0.73), social relationships (0.65 to 0.77), and environmental (0.52 to 0.75) subscales (Hill 
et al., 2010).  
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When the WHOQOL-BREF was compared to the Short Form-36 (SF-36; Ware, 
Snow, Kosinski, & Gandek, 1993), both measures demonstrated very good internal 
consistency (Cronbach’s α coefficients of 0.72 to 0.98 and 0.75 to 0.84, respectively), 
intra- and interrater reliability (intraclass correlation coefficients of 0.41 to 0.98 and 0.56 
to 0.95), and convergent validity among the conceptually related domains (Lin, Hwang, 
Chen, & Chiu, 2007).  The WHOQOL-BREF has lower ceiling and floor values than the 
SF-36.  
The Brief COPE.  Coping was measured by the Brief COPE (Carver, 1997).  The 
Brief COPE consists of 14 2-item scales.  Respondents mark their uses of each of the 
coping options in dealing with the stressful encounters in their current situations.  The 
scale ranges from 1 (“I haven’t been doing this at all”) to 4 (“I’ve been doing this a lot”).  
The Brief COPE can measure the following constructs: (a) problem-focused coping 
(including active coping [items 2 and 7], self-distraction [items 1 and 19], positive 
reframing [items 12 and 17], planning [items 14 and 25], and use of instrumental support 
[items 10 and 23]), (b) emotion-focused coping (including use of emotional support 
[items 5 and 15], behavioral disengagement [items 6 and 16], venting [items 9 and 21], 
religion [items 22 and 27], and substance abuse [items 4 and 11]).  Four constructs do not 
fall into these categories: self-blame (items 13 and 26), humor (items 18 and 28), 
acceptance (items 20 and 24), and denial (items 3 and 8).  The scores are not typically 
evaluated as an overall coping index.  Test-retest reliability shows r = .60 and is 
considered acceptable, along with the validity at .72 (Carver, 1997).  
Multidimensional Scale of Perceived Social Support.  The Multidimensional 
Scale of Perceived Social Support (MSPSS) is a validated 12-item instrument designed to 
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assess perceptions about support from family, friends, and significant others.  This scale 
was developed by Zimet, Dahem, Zimet, and Farley in 1988.  The items are divided into 
factor groups relating to the source of support, with scores ranging from 1 to 7 on a Likert 
scale.  High scores indicate high levels of perceived support and low scores indicate low 
levels of perceived support.  This scale was studied and validated using adolescent and 
adult outpatient populations (Zimet et al., 1988).  Social support is believed to contribute 
a moderating influence between stressful life events and depression. 
Initial MSPSS reliability was demonstrated, with good internal reliability and 
good stability.  The sample size was 275, with coefficient α for the subscales and scale as 
whole ranging from .85 to .91 and test-retest values ranging from .72 to .85 (Zimet et al., 
1988).  In addition, adequate MSPSS content validity was demonstrated by Zimet et al., 
(1988). 
Procedure 
This study was conducted online via SurveyMonkey in an effort to reach the 
specialized SLE female population and recruit individuals who otherwise may not have 
been able to participate due to limitations in mobility and/or lack of transportation.  The 
responsible investigator created a research study announcement, flyer, and cover letter.  
The announcement informed prospective participants of the purpose of the study and 
expected duration of participation.  The flyer informed potential participants of the 
purpose of the study, inclusion and exclusion criteria, anticipated duration, the Internet 
web address to access the study, and contact information for the researcher, advisor, and 
research coordinator.  The cover letter included a description of the study, an explanation 
of what participation would entail, and a description of the risks and benefits of 
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participating.  Participants were recruited on the Internet.  The study announcement was 
posted to several discussion forums and online lupus support groups.  In an effort to 
recruit more participants, prospective participants were requested to forward the survey 
link on to other interested individuals. 
All participants were provided with a SurveyMonkey link and IP addresses were 
not recorded.  If a potential participant clicked on the link, he or she was provided with 
an extensive explanation related to the conditions of participation, including that 
participation would be anonymous (with no potential for identifying or linking responses 
to the respondent), that participation was voluntary, that a person could withdraw from 
the study at any time without consequences, that the known risks were minimal (but that 
the person may find out something about himself or herself that could be mildly 
upsetting), that there would possibly be potential benefits to participation for others, that 
completing the questionnaires would make him or her eligible for a raffle to win one of 
two $50 gift cards, and that if he or she had any questions, he or she could reach out to 
the principal or responsible investigators. 
Potential participants were asked to respond as to whether they understood the 
terms and conditions of participation and those who agreed to participate were given a 
series of inclusion/exclusion criteria-related questions.  Those who met the inclusion 
criteria had the opportunity to participate.  Those who did not were be informed that they 
did not meet eligibility to participate and were thanked.  Once a participant completed all 
of the questionnaires, he or she was given an opportunity to participate in a raffle.  Each 
participant was informed that he or she should e-mail the responsible investigator to 
participate and that these e-mails would not in any manner be tied to survey responses. 
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The responsible investigator composed a brief inclusion/exclusion demographic 
and diagnostic questionnaire, using standard questions that have been accepted for use 
with female SLE patients, to ensure inclusion criteria were met and exclusion criteria 
were not met.  No identifying information was collected, and all participants  remained 
anonymous.  The measures being used in the study (ICD, WHOQOL-BREF, SSB, and 
COPE) were administered electronically, which allowed users to create and share 
questionnaires on the Internet and allowed respondents to remain anonymous.  The 
researcher gained approval from the author of the ICD, Robert DiTomasso, authors of the 
WHOQOL-BREF, the World Health Organization, to use and administer the measures 
electronically for the purpose of this research. 
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Chapter 4: Results 
 In discussing the results of this study, it must be noted that the Brief COPE was 
modified in a manner that has not been used previously, which may have affected validity 
and reliability.  When indicated, items were reverse scored and a total score for the scale 
was calculated as a measure of positive coping.  Coefficient α for the entire scale was 
calculated to be .95, supporting the use of an overall coping index.  Scores on the 
individual coping scales were not calculated as is usually done.  As such, the results 
should be interpreted with caution.  
Demographic Analyses 
In this study, 100% of the participants were female and had been diagnosed with 
lupus for at least one 1 year prior to recruitment.  Participants fell between the ages of 18 
and 55 years.  All participants reported having at least an eighth-grade educational level 
and reported being fluent in spoken and written English.  Correlations, means, and 
standard deviations can be found in Table 1. 
 
 
Table 1 
 
Means and Standard Deviations for Variables the Coping, Cognitive Distortions, Social 
Support, and QOL 
 
 N Mean Std. 
Deviation 
 
ICD 62 215.9032 58.56024  
WHOQOL 62 61.1935 22.72418  
MSPSS 62 43.1452 17.08498  
Brief Cope 62 61.3548 19.76012  
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Analysis of Hypotheses 
All correlational findings are shown in Table 2.  Hypothesis 1 predicted that there 
would be a significant negative relationship between the total score on the ICD and QOL 
measure.  A Pearson correlation coefficient was computed and a significant negative 
relationship was found, r = -.704, p < .001.  Based on the fact that including Hypothesis 
1, there were four analyses conducted on the same set of data, a Bonferroni correction 
was calculated as .05 divided by 4 = .01.  Using the Bonferroni correction, the finding for 
Hypothesis 1 was supported.  The coefficient of determination revealed that 49.5% of the 
variability in scores on WHOQOL-BREF were attributable to differences in scores on the 
ICD.  In other words, almost 50% of the variability in QOL is attributable to differences 
in distorted thinking. 
Hypotheses 2 predicted that there would be a significant positive correlation 
between social support as measured by the MSPSS and scores on the WHOQOL-BREF.  
Bonferroni correction was calculated to be .01.  As shown in Table 2, a Pearson 
correlation coefficient revealed a high and significant relationship between social support 
and quality of life, r = .823, p <.001.  The coefficient of determination demonstrates that 
almost 68% of the variability in self-reported QOL is attributable to differences in social 
support.  
Hypotheses 3 predicted that Brief COPE scores would be significantly and 
positively related to WHOQOL-BREF scores.  The Bonferroni correction was calculated 
to be .01.  As shown in Table 2, a Pearson correlation coefficient revealed a positive and 
significant correlation between these two variables, r = .882, p < .01.  The coefficient of 
determination revealed that 77.7% of the variability in QOL is attributable to differences 
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in coping.  It is important to note that in the calculation model, negative coping items 
(denial: items 3 and 8; substance use: items 4 and 11; behavioral disengagement: items 6 
and 16; self-blame: items 13 and 26) were reverse scored, as noted above.  Coefficient α 
for the entire scale was calculated to be .95, supporting the use of an overall coping 
index.  Scores on the individual coping scales were not calculated as is usually done.  As 
such, the results should be interpreted with caution.  
 
 
Table 2 
Correlations Between the Predictors and Criterion for Coping, Cognitive Distortions, 
Social Support, and QOL 
 
 QOL Coping Cognitive 
Distortions 
Social 
Support 
Pearson 
Correlation 
1 .882 -.704 .823 
N 62 62 62 62 
Sig. (1-tailed) .000 .000 .000 .000 
 
 
 Hypotheses 4 predicted that the linear combination of coping, cognitive 
distortions, and social support would significantly predict QOL.  Specifically, it was 
hypothesized that scores on the Brief COPE would predict higher QOL, scores on the 
ICD would predict lower QOL, and social support would predict higher QOL.  In 
conducting this analysis, correlations of each predictor with the criterion were calculated 
and each of the predictor variables correlated with the QOL criteria (see Table 2).  Based 
on this analysis, the decision was justified for including all three predictors into the 
regression equation; however, before utilizing the three predictors, a multicollinearity 
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analysis was conducted.  First, Pearson correlations between the predictors were 
considered, and according to Field (2017), intercorrelations between predictors that fall 
around .80  or above may indicate multicollinearity.  Of all of the predictors, MSPSS and 
the Brief Cope correlated, r = .80, Brief Cope and ICD correlated, r =  -.705, and the ICD 
and the MSPSS scale correlated, r = .685.  To further examine the potential for 
multicollinearity, variance inflation factors and tolerance statistics were considered using 
Field’s criterion.  Variance inflation factors greater than 10 would indicate a concern and 
tolerance statistics below .10 would be considered serious as indications for 
multicollinearity. 
As shown in Table 3, in the present study, the tolerance levels and VIF values 
were considered appropriate.  Therefore, multicollinearity was not considered a potential 
threat in the current study.  In addition, the assumption of independent errors was tested 
with the Durbin-Watson statistic.  According to Field (2017), the Durbin-Watson tests 
“for serial correlation between errors in a regression model . . . specifically whether 
adjacent residuals are correlated” (p. 740).  Field stated that values less than 1 or greater 3 
are concerning, and that the closer the value is to 2, the more likely an assumption will 
have been met.  In the present study, the Durbin-Watson statistic was 1.78, indicating the 
assumption of independent errors was met.  The results of the multiple regression 
analysis are shown in Tables 3, 4 and 5.  Using the Brief COPE, ICD, and MSPSS scores 
as predictors revealed a multiple of .904 with a coefficient of determination .817.  
The adjusted coefficient of determination was .808, revealing very little if any shrinkage. 
The F value was significant at p < .001 and the overall ANOVA source table revealed a 
significant F.  These findings reveal the set of predictors are significantly predicting the 
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criterion at a better than chance level.  A test of the individual predictors revealed that 
only social support and coping made significant contributions to the prediction of the 
QOL.  The linear combination of social support and coping is useful in predicting QOL.  
It should be noted that the histogram for QOL conforms relatively well to a normal 
distribution; however, there was some deviation from normality as noted on the pp-plot 
of standardized residuals.  The scattered plot of QOL reflected regression standardized 
predicted values against regression standardized residuals, which supported a normal 
distribution and homoscedasticity. 
 
 
Table 3 
Model 1 Summary of Predictor Variables (Brief COPE, ICD Total Score, Social Support) 
to the Criterion Variable (QOL) 
 
Model R R 
Square 
Adjusted 
R 
Square 
Std. 
Error of 
the 
Estimate 
R 
Square 
Change 
F 
Change 
Df1 Df2 Sig. F 
Change 
1 .904 .818 .808 9.95494 .818 86.618 3 58 .000 
 
 
Table 4 
Overall Regression Analysis with Predictor Variables (Coping, Cognitive Distortions, 
Social Support) to the Criterion Variable (QOL) 
 
Model  Sum of Squares Df Mean Square F Sig. 
1   Regression 25751.826 3 8583.942 86.618 .000 
     Residual 5747.852 58 99.101  
     Total 31499.677 61   
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Table 5 
Coefficients of Predictor Variables (Coping, Cognitive Distortions, Social Support) to the 
Criterion Variable (QOL) 
 
Model Unstandardized 
Coefficients 
B      Std. Error 
Standardized 
Coefficients 
    Beta 
 
 
T 
 Collinearity 
      Statistics 
Sig  Tolerance   
 
 
VIF 
1(Constant) 11.814  11.760  1.005 .319    
ICDTotalSc -.038     .032     -.097 -1.181 .243   .464           2.154 
SocSupp .378       .132     .284 2.865 .006    .320         3.121 
BriefCope .672       .117            .584 5.743 .000    .304         3.291 
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Chapter 5: Discussion 
Lupus is a chronic disease that has increased in prevalence and awareness over 
the last two decades.  With such increased awareness, more research has been conducted 
examining factors impacting the QOL of individuals with this disease.  Although such 
research has been beneficial in uncovering various variables related to QOL within this 
population, many of the variables that have been identified (e.g., gender, age, presence of 
comorbid illness, etc.) cannot be modified within a clinical setting due to their fixed 
nature.  In light of this, and to help improve the QOL of this group, the current study 
aimed to increase the understanding of factors which may be amenable to treatment.  In 
particular, the relationship between cognitive distortions, social support, coping skills, 
and QOL in female individuals with SLE was examined. 
The results of this study indicated that the QOL for a females with SLE is 
significantly associated with  cognitive distortions (i.e., dysfunctional thoughts) along 
with social support and coping skills in the presence of medical symptoms.  For females 
with SLE, psychological well-being is related to perception regarding the ability to 
manage obstacles and challenges, and to experiences of uncomfortable physical 
symptoms and distressing psychosocial issues.   
The results of the present study further indicated that perceived QOL in regard to 
social relationships is influenced by the presence of a cognitive distortions, social 
support, and coping skills.  Thus, although not inferring causality, the perceived nature of 
an individual’s social QOL may be negatively affected by her belief that she cannot 
manage the problems in her life, and the presence of distressing physical symptoms 
associated with cognitive distortions. 
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This research illuminated the interaction between external and internal events, 
specifically, the role of the interpretation of events on an autoimmune disease such as 
lupus in relation to emotional processes and perceived well-being.  These results may 
imply the importance of the role of CBT in potentially helping patients alter 
dysfunctional and distorted cognitions to improve QOL, learn efficient coping skills, and 
become active in helpful social support resources.  Whereas past studies have assessed 
psychosocial issues associated with female SLE patients, these studies were limited by 
the use of measures that assess for only select disorders.   
CBT interventions are well suited to reduce specific cognitive distortions in 
this population.  Specifically, using cognitive restructuring for both emotional reasoning 
and decision making, clinicians can teach patients the cognitive model, that thoughts 
influence emotional states and behaviors reciprocally, helping them identify and 
challenge distorted and dysfunctional thoughts.  Patients can learn to replace distorted or 
dysfunctional thoughts with more accurate or adaptive thoughts and can learn problem-
solving skills to help them rely less on emotions for reasoning and decision making.  
Patients can also be taught to distinguish between fact versus an emotional state.  
Techniques such as a cost-benefit analysis, vertical descent, or the double-standard 
exercise can be useful tools to illustrate this concept (Leahy, 2003).  Problem-solving 
therapy, which facilitates adoption of a more adaptive problem orientation, such as being 
optimistic in believing that one can cope with and resolve feelings of hopelessness and 
doubt rather than believing one’s situation will never improve, is another avenue by 
which one can learn to challenge emotional reasoning and decision making and improve 
one’s life (A. M. Nezu & C. M. Nezu, 2001). 
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For the cognitive distortion of comparison to others, clinicians can help patients 
to refrain from comparing themselves to others and shift their focus to personal strengths 
and retained abilities, which may permit them to think more adaptively.  Leahy (2003) 
suggested the use of positive tracking, or keeping a journal of positive experiences or 
actions to help shift focus to positive qualities rather than perceived shortcomings.  
Patients can then praise themselves for their positives, which may serve to increase 
positive behaviors.  Identifying and correcting these frequent distortions can enhance 
QOL and facilitate adjustment to disability.  In positive psychology, interventions aim to 
help people shift their focus from misfortune and what has gone wrong in life to blessings 
and what has gone right (Seligman, Rashid, & Parks, 2006).  One such positive 
psychology technique that seems particularly well suited to this population is the three 
blessings exercise, in which lupus patients can be encouraged to identify three things that 
they are most happy with at the end of the day and how they contributed to the three 
blessings going well, in order to add gratitude and optimism to life, in addition to 
increasing self-efficacy by recognizing their own contributions. 
Findings and Clinical Implications 
Cognitive distortions and quality of life.  The current study found that high 
levels of distorted thinking were highly correlated with lower QOL, which is a known to 
highly correlate with depression.  These results corroborate much of what has been 
demonstrated previously in the literature (Shapiro, 2007).  These findings suggest that 
when unhelpful thinking patterns such as all-or-nothing thinking, discounting the 
positives, emotional reasoning, jumping to conclusions, labeling, magnification, mental 
filter, overgeneralization, blaming and personalization, and should-statements are present 
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in female adults with lupus, these individuals often present and report experiencing an 
overall lower QOL.  As such, clinically, it is important for clinicians to screen for these 
cognitive distortions when treating female adults with lupus and to modify treatment 
accordingly.  
Social support and quality of life.  The present study found there to be a high 
and significant relationship between social support and QOL.  The role of social support 
in chronic disease, such as cancer, has been widely researched; however, its impact on 
SLE has not been well confirmed.  Sutcliffe et al. (2001) reported a higher level of 
perceived social support was associated with better QOL, except for in the role-emotional 
domain.  This study’s results indicate social support is a contributor of better QOL among 
lupus patients, perhaps due to the buffering properties of social support.  Social support 
can buffer the effects of stressful life events leading, subsequently, to higher QOL.  
Clinically, social support can help a patient adjust to life with a disease.  Individuals who 
have higher levels of perceived social support can manage situations more effectively, 
even in the most difficult situations, whereas lower levels of perceived social support 
contribute to poor outcomes (Zheng et al., 2009).  
Coping and quality of life.  The present study found there to be a strong and 
significant relationship between coping and QOL.  Coping can help patients become 
stronger to deal with the disease and other important life events, relieving their suffering.  
This study’s results indicate positive coping strategies are a contributor of better QOL 
among lupus patients.  These finding support some of what has been demonstrated 
previously in the literature (Navarrete-Navarrete et al., 2010).  Psychotherapeutic 
treatment can lead patients to better cope with illness and increase adherence to medical 
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treatment.  In past research, it was shown that after treatment, patients handled their 
bodies and diseases differently, minimizing the importance of symptoms that were felt 
before as severe and harmful, which interfered in their daily activities (Navarrete-
Navarrete et al., 2010).  Incorporating occupational activity, treatment, humor, and self-
image in female lupus patients may lead to positive changes in coping strategies and be 
effective in improving QOL. 
From a clinical perspective, the results further underscore the importance of 
appropriate psychological assessments during the course of medical treatment with 
female adults with lupus.  The presence of lack of support, cognitive distortions, and poor 
coping in adult female lupus patients is likely to predict frequent episodes of depression 
and a poor QOL.  This increased frequency of cognitive distortions may exacerbate many 
of the functional difficulties already experienced by female adults with lupus, which are 
well-documented in the literature impact mood, and further decrease QOL (Weissman, 
1979).  Therefore, it is essential for medical clinicians to be aware of the impact mood 
disorders as well as maladaptive personality features can have on their clients’ clinical 
presentations and life difficulties.  Physicians can refer patients to mental health 
clinicians who can provide treatment accordingly so that cognitive distortions can be 
addressed adequately.  CBT is uniquely qualified in this regard.  According to J. S. Beck 
(2011), cognitive distortions are the result of a “systematic negative bias [or inaccuracy] 
in . . . cognitive processing” (p. 179) found in individuals suffering with a wide variety of 
psychiatric disorders.  Underlying maladaptive core beliefs and intermediate beliefs give 
rise to negative or otherwise distorted automatic thoughts.  These maladaptive automatic 
thoughts, which are often distorted, can in turn lead to psychiatric disorders such as 
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anxiety and depression (Mathews & MacLeod, 2005).  Successful CBT involves 
identification of the cognitive distortions and dysfunctional core beliefs, and “direct 
modification of their core beliefs as soon as possible” so that clients may begin to view 
their current and future problems more adaptively (J. S. Beck, 2011, p. 35).  As such, the 
ICD may be a particularly advantageous measure to use during the course of specialist 
visits for medical treatment for female adults with lupus, as it identifies cognitive 
distortions, which may quickly alert medical providers to refer patients to obtain 
psychological counseling, treatment, and/or social support resources. 
The role of the psychologist.  Based on the findings of this study, living with 
lupus can have a profound effect on a person’s mental and emotional well-being.  
Therefore, it is imperative that a psychologist be involved in assessing the individual’s 
and family’s psychological status and ability to cope with the unpredictable nature and 
changing health status associated with lupus.  The psychologist may be able to tailor a 
treatment plan to meet the needs of the patient and provide a wide range of interventions.  
Psychological therapy may include short-term interventions such as CBT or other 
evidence-based treatments for depression, anxiety, and poor self-image; treatment for 
sleep disturbance; mindfulness training; guided imagery; breathing exercises; relaxation 
training; and/or exercise therapy.  These interventions have also been beneficial for 
dealing with other adjustment issues and/or improving symptom management and 
functioning, crisis management, and reducing maladaptive behaviors. 
 Studies have shown that a combination of psychoeducational and 
psychotherapeutic interventions significantly improve outcomes in patients with lupus 
(Magro-Checa, Zirkzee, Huizinga, & Steup-Beekman, 2016). Some patients can benefit 
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from training in behavioral charting. Identifying patterns and associations between flares, 
stressors, pain, and physical activities can be helpful and may increase patients’ perceived 
control and hope for the future. Exercise can increase mobility and/or flexibility by 
helping to build muscle tone and strength, and low-impact and moderate activities, such 
as stretching, walking, or aqua aerobics, may benefit management of the disease. 
Appropriately addressing the mental health issues associated with SLE through patient 
education programs, psychological assessment and interventions has been shown to 
reduce healthcare costs and lessen the complications of the disease (Danoff-Burg, & 
Friedberg, 2009). 
 The psychologist may also interact with rheumatologists and psychiatrists when 
combined psychological and medication treatments are needed.  The psychologist can be 
involved in program planning, validation, and research, as well as the development and 
validation of assessment measures.  A neuropsychologist, who specialize in the 
functioning of the brain, should have the knowledge and training to become involved 
with persons with lupus when there are questions or concerns about changes in cognitive 
functioning. 
Limitations 
There are limitations in the present study that should be considered when 
evaluating the results.  A major limitation of this study was the failure to obtain 
demographic characteristics of the sample.  Although inclusion-exclusion criteria provide 
some information, the absence of other demographics precluded additional analysis and a 
more exact description of the sample.  More specifically, it would have been useful to 
know each participant’s specific age, age of onset of the diagnosis, year of diagnosis, 
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other psychiatric conditions, current involvement in and history of psychotherapy, 
psychotropic and other medications being taken, other medical conditions, marital status, 
and ethnicity. 
An additional limitation to this study is that it would have been preferable to 
randomly counterbalance the order in which the questionnaires were presented to the 
participants.  By not doing so, the results were limited by the possible order effects 
related to the presentation of the questionnaires in the standard order that was used.  The 
potential impact of completing the questionnaires in a given order is, then, not distributed 
equally across the subjects.  A related issue is that participants may have been fatigued by 
the end of the entire survey, which may have impacted the completion of the last 
questionnaire. 
Another important challenge to note was the difficulty in securing participants for 
the study.  There was a limitation related to self-selection, to the extent that there may be 
something unique about those who chose to participate.  For example, these individuals 
might differ in some important ways on their level of impairment, distorted thinking, 
levels of available social support, coping, or QOL.  This had implications for 
generalization of the findings.  Due to the aforementioned lack of a demographic 
questionnaire, it was not possible to compare those who participated from those who met 
inclusion criteria but dropped out. 
An additional notable limitation to the current study is that participation may be 
limited to those with Internet access, who visit lupus-related websites/discussion forums 
and attend lupus-related support events.  This may lead to selection bias, as it is unknown 
whether female lupus patients who frequent these sites differ from lupus patients who do 
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not.  For example, those with the most severe cases of lupus may not be physically able 
to access the Internet.  Although using a convenience sample improved the ability to 
reach out to this specialized population, generalizability was threatened.  
An added limitation of note involves the use of self-report measures, as these are 
reactive measures, and respondents may not have answered truthfully (Kazdin, 2003).  
Ideally, it could be useful to use multimethod approach with behavioral, physiological, 
and/or collateral data.  Also, the WHOQOL-BREF, Brief COPE, MSPSS, and ICD have 
not validated for use with lupus patients.  Regarding the ICD specifically, this population 
may require the use of a measure designed specifically for lupus patients that targets 
distortions related to the challenges resulting from the health condition.  Unfortunately, 
no such measure exists.  
Another limitation of the present study is that women with various clinical 
presentations of lupus were not examined within the study.  It may be that women with 
particular subtypes or clinical manifestations (e.g., kidney complications as compared to 
gastrointestinal issues) of lupus could be more likely to present with cognitive distortions 
than those diagnosed with other subtypes.  Examining subtypes could help explain the 
discrepancy between the current results and previous findings. 
Future Directions 
Because the current results are supportive of all of the proposed hypotheses, it 
will be especially important for future research to replicate and expand on the current 
findings.  One particularly useful way to expand on the current findings would be to 
examine different lupus populations.  For instance, future research should replicate this 
study in a community-based rheumatology clinic where there may be a sample more 
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representative of the average female adult with lupus, or where a more diverse sample 
could be obtained.  Additionally, replicating this study with adolescents and older adults 
would be conceptually informative, to discover whether puberty or other age-related 
physical developmental milestones that become present over time impact coping, 
cognitive distortions, social support, and/or QOL. 
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